FGFR2 Gene and Breast Cancer Risk
Author Information
Author(s): Kerstin B. Meyer, Ana-Teresa Maia, Martin O'Reilly, Andrew E. Teschendorff, Suet-Feung Chin, Carlos Caldas, Bruce A. J. Ponder
Primary Institution: Cancer Research UK, Cambridge Research Institute
Hypothesis
Does the up-regulation of FGFR2 increase susceptibility to breast cancer?
Conclusion
The study found that specific genetic variations in the FGFR2 gene are associated with increased expression of the gene, which may contribute to a higher risk of developing breast cancer.
Supporting Evidence
- The FGFR2 gene is associated with a small but significant increase in breast cancer risk.
- Increased FGFR2 expression was observed in tumors with the rare homozygous genotype.
- Two specific SNPs were identified that alter transcription factor binding and increase FGFR2 expression.
Takeaway
Some people have a gene that makes them more likely to get breast cancer. This study looked at how changes in that gene can make it work more, which might lead to more cancer.
Methodology
The study used genetic mapping, gene expression analysis, and protein-DNA interaction assays to investigate the role of FGFR2 in breast cancer susceptibility.
Potential Biases
Potential bias may arise from the selection of tumor samples and the specific populations studied.
Limitations
The study primarily focused on European populations, which may limit the generalizability of the findings to other ethnic groups.
Participant Demographics
The study involved European individuals with breast cancer.
Statistical Information
P-Value
0.028
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website